UBE2L3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.668800E-01
Normal-vs-Stage2
7.820000E-01
Normal-vs-Stage3
7.332600E-01
Normal-vs-Stage4
9.582200E-01
Stage1-vs-Stage2
6.940400E-01
Stage1-vs-Stage3
9.685000E-01
Stage1-vs-Stage4
6.580800E-01
Stage2-vs-Stage3
7.067400E-01
Stage2-vs-Stage4
8.134800E-01
Stage3-vs-Stage4
7.595600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.373400E-01
Normal-vs-AfricanAmerican
9.287600E-01
Normal-vs-Asian
7.549600E-01
Caucasian-vs-AfricanAmerican
7.397800E-01
Caucasian-vs-Asian
2.381400E-01
AfricanAmerican-vs-Asian
6.224000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.323600E-01
Normal-vs-Female
9.795200E-01
Male-vs-Female
3.065800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.441500E-02
Normal-vs-Age(41-60Yrs)
8.840600E-01
Normal-vs-Age(61-80Yrs)
6.680600E-01
Normal-vs-Age(81-100Yrs)
5.197800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.110100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.546400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.848030E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.233500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.870600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.665800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.405200E-01
Normal-vs-Daily Drinker
5.436800E-01
Normal-vs-Weekly Drinker
7.464400E-01
Normal-vs-Occasional Drinker
7.225400E-01
Normal-vs-Social Drinker
6.651200E-01
Non Drinker-vs-Daily Drinker
9.694400E-01
Non Drinker-vs-Weekly Drinker
9.120000E-02
Non Drinker-vs-Occasional Drinker
5.812400E-02
Non Drinker-vs-Social Drinker
3.236600E-01
Daily Drinker-vs-Weekly Drinker
1.177440E-01
Daily Drinker-vs-Occasional Drinker
7.310400E-02
Daily Drinker-vs-Social Drinker
3.828000E-01
Weekly Drinker-vs-Occasional Drinker
8.637200E-01
Weekly Drinker-vs-Social Drinker
3.075000E-01
Occasional Drinker-vs-Social Drinker
1.905230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.972600E-01
Normal-vs-Grade 2
8.506600E-01
Normal-vs-Grade 3
8.160400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.563700E-02
Grade 1-vs-Grade 3
5.668600E-01
Grade 1-vs-Grade 4
7.972600E-01
Grade 2-vs-Grade 3
1.363620E-01
Grade 2-vs-Grade 4
8.506600E-01
Grade 3-vs-Grade 4
8.160400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.271800E-01
Normal-vs-NonDiabetic
9.133000E-01
Diabetic-vs-NonDiabetic
8.037900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.799200E-01
Normal-vs-NoPancreatitis
7.321400E-01
Pancreatitis-vs-NoPancreatitis
5.266200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.747200E-01
Normal-vs-N1
8.526400E-01
N0-vs-N1
5.547800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.662200E-01
Normal-vs-TP53-NonMutant
5.278000E-01
TP53-Mutant-vs-TP53-NonMutant
5.367900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
